Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Patients With Partial Onset Seizures With or Without Secondary Generalization

NCT02726074 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT02726074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Patients With Partial Onset Seizures With or Without Secondary Generalization
Lead sponsor
Eisai Korea Inc.
Phase
Phase 4
Overall status
Completed
Start date
May 3, 2016
Completion date
April 26, 2018
Enrollment
106 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy